| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |